Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Is it better to take these on an empty stomach
10.1289/ehp11813
314 In a 54-week, randomized, placebo-controlled trial in 834 adults with overweight or obesity and type 2 diabetes inadequately controlled with metformin, daily 300 mcg subcutaneous injections of cotadutide were found to elicit greater weight loss and reduce non-biopsy markers of NAFLD and fibrosis better than daily 1.8 mg subcutaneous injections of liraglutide
Evidence map Evidence boundaries Factory batch documentation No factory batch COA is published for this product yet
US$ 22.69
.svg)
US$ 27.66
US$ 28.88
US$ 26.87
